Health ❯ Healthcare

Cholesterol Management

Statins LDL Cholesterol Heart Disease PCSK9 Gene Statin Therapy Statin Use Hypercholesterolemia Atorvastatin Familial Hypercholesterolemia Cardiovascular Health Cholesterol Drugs Weight Loss Medications Lipid-Lowering Therapy Medication

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

Phase 3 trials showed roughly 56–59% reductions in LDL cholesterol and the pill will carry a $315 monthly list price.

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

ACC/AHA Overhaul Cholesterol Care With Earlier Screening, New Risk Tool and Clear LDL Targets

Major Lancet Analysis Finds Most Statin Label Side Effects Not Caused by the Drugs

Major Lancet Meta-Analysis Finds Statins Don’t Cause Most Listed Side Effects

Review: Cutting Saturated Fat Helps High-Risk Patients, Shows Little Gain for Others

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

Eli Lilly to Acquire Verve Therapeutics as Gene-Editing Trial Begins